Importantly, downregulation of Jab1 sensitized HCC cells to cisplatin (Guo et al., 2016), indicating that Jab1/p57 pathway render chemotherapy resistance and may represent a potential target for treatment of HCC. Here, CDKN1C is linked to hepatocellular carcinoma.